Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma

Dendritic cells (DCs) are the most potent antigen-presenting cells, and have thus been used in clinical cancer vaccines. However, the effects of DC vaccines are still limited, leading researchers to explore novel ways to make them effective. In this study, we investigated whether human monocyte-deri...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Tan-Huy Chu, Manh-Cuong Vo, Thangaraj Jaya Lakshmi, Seo-Yeon Ahn, Mihee Kim, Ga-Young Song, Deok-Hwan Yang, Jae-Sook Ahn, Hyeoung-Joon Kim, Sung-Hoon Jung, Je-Jung Lee
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2022-06-01
Saila:	Translational Oncology
Gaiak:	Immunology T cells cytokine induced killer cells natural killer cells multiple myeloma
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S1936523322000754
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!